Schedule 13G ownership disclosure

HORIZON THERAPEUTICS PUB L

Security class unavailable · CUSIP: G46188101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
20,138,694
Percent of class
8.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-017763
Form type
SC 13G/A
Filer
Horizon Therapeutics Public Ltd Co
CIK
CIK 1492426
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub